EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Pre-Existing Subclinical Leg Lymphedema in Patients with Erysipelas

Eva Klara Merzel Šabović iD, Tanja Planinšek Ručigaj

Journal of Cutaneous Medicine and Surgery · 2025

DOI: 10.1177/12034754241308239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2025. Verfasst von Eva Klara Merzel Šabović und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dermatovenerology Clinic, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Erysipelas, Lymphedema. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Erysipelas is a common bacterial infection of the skin and subcutaneous tissue. In certain patients, the triggering factor can be identified, but in many cases, it remains elusive. Prior research indicates that pre-existing subclinical lymphedema in patients might serve as a triggering factor for the development of erysipelas.

Objectives

We investigated the prevalence of subclinical lymphedema on the unaffected leg in patients with a recent history of erysipelas by performing lymphoscintigraphy of both legs.

Methods

In a prospective study, 106 consecutive patients (mean age 53.4 years; 87/19: men/women) 3 to 6 months after erysipelas episode were included in the study. In all patients, lymphoscintigraphy was performed by subcutaneous injection of Tc-99m-labelled human albumin into both feet according to standard protocol.

Results

Subclinical lymphedema on the unaffected leg was found in 82% of patients, with a similar prevalence in all genders and age groups, and in patients with or without erysipelas risk factors. Moreover, the prevalence of subclinical lymphedema increased proportionally with the number of erysipelas episodes: among those with a single episode, 74% exhibited subclinical lymphedema, whereas among those with 3 or more episodes, the prevalence was 100%.

Conclusions

We found a high prevalence of subclinical lymphedema in the unaffected leg in erysipelas patients, indicating its frequent bilateral occurrence and its role as a primary trigger of erysipelas. Moreover, our study highlights subclinical lymphedema as a risk factor for erysipelas recurrences. Thus, our clinical recommendation suggests bilateral leg compression therapy in erysipelas patients to prevent recurrence and lymphedema exacerbation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErysipelasLymphedemaHumansMaleMiddle AgedFemalePrevalenceProspective StudiesLegAgedAdultLymphoscintigraphyRisk Factors

Stichwörter der Autor:innen

cellulitiserysipelaslymphatic systemlymphoscintigraphysubclinical lymphedema

Autor:innen und Institutionen

  • Dermatovenerology Clinic, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Eva Klara Merzel Šabović

Zitieren

APA

Merzel Šabović, E. K., & Planinšek Ručigaj, T. (2025). Prevalence of Pre-Existing Subclinical Leg Lymphedema in Patients with Erysipelas. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754241308239

Vancouver

Merzel Šabović EK, Planinšek Ručigaj T. Prevalence of Pre-Existing Subclinical Leg Lymphedema in Patients with Erysipelas. Journal of Cutaneous Medicine and Surgery. 2025. doi:10.1177/12034754241308239

BibTeX
@article{Merzelabovi2025,
  author = {Merzel Šabović, Eva Klara and Planinšek Ručigaj, Tanja},
  title = {Prevalence of Pre-Existing Subclinical Leg Lymphedema in Patients with Erysipelas},
  journal = {Journal of Cutaneous Medicine and Surgery},
  year = {2025},
  doi = {10.1177/12034754241308239}
}
Kostenlos starten →